Cecha
Abnormal heart rate
Nazwa kliniczna: Arrhythmia
Any cardiac rhythm other than the normal sinus rhythm. Such a rhythm may be either of sinus or ectopic origin and either regular or irregular. An arrhythmia may be due to a disturbance in impulse formation or conduction or both.
Podsumowanie
- Znana także jako
- Heart rhythm disorders, Irregular heart beat, Irregular heartbeat, Arrhythmias, Cardiac arrhythmia, Cardiac arrhythmias, Cardiac rhythm disturbances
- Układ organizmu
- Abnormality of the cardiovascular system
Genom referencyjnyGRCh38hg38
Pozycje na stronach genów i wariantów zależą od tego wyboru, w tej przeglądarce.
Read the genes linked to Abnormal heart rate, and the rest of your genome, with one test.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni
Zamawiam Genome Test239 genów powiązanych z Abnormal heart rate
Zmiany w tych genach powodują rzadkie choroby, w których występuje Abnormal heart rate. Większość osób z tą cechą nie ma żadnej z tych chorób, a gen z tej listy nic nie mówi o czyimkolwiek własnym genomie.
| Gen | Jak często występuje | Choroby |
|---|---|---|
| CRELD1CRELD disulfide isomerase 1 | Zawsze | W 1 chorobie |
| JKAMPJNK1/MAPK8 associated membrane protein | Zawsze | W 1 chorobie |
| LMNAlamin A/C | Zawsze | W 5 chorobach |
| OAS22'-5'-oligoadenylate synthetase 2 | Zawsze | W 1 chorobie |
| TOP3ADNA topoisomerase III alpha | Zawsze | W 1 chorobie |
| TTNtitin | Zawsze | W 2 chorobach |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 2 chorobach |
| ELNelastin | Bardzo często (80–99%) | W 1 chorobie |
| GPX4glutathione peroxidase 4 | Bardzo często (80–99%) | W 2 chorobach |
| JUPjunction plakoglobin | Bardzo często (80–99%) | W 1 chorobie |
| NKX2-5NK2 homeobox 5 | Bardzo często (80–99%) | W 3 chorobach |
| PHOX2Bpaired like homeobox 2B | Bardzo często (80–99%) | W 1 chorobie |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Bardzo często (80–99%) | W 2 chorobach |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Bardzo często (80–99%) | W 4 chorobach |
| SCNN1Asodium channel epithelial 1 subunit alpha | Bardzo często (80–99%) | W 2 chorobach |
| SCNN1Bsodium channel epithelial 1 subunit beta | Bardzo często (80–99%) | W 2 chorobach |
| SCNN1Gsodium channel epithelial 1 subunit gamma | Bardzo często (80–99%) | W 2 chorobach |
| SLC25A20solute carrier family 25 member 20 | Bardzo często (80–99%) | W 1 chorobie |
| TSPYL1TSPY like 1 | Bardzo często (80–99%) | W 1 chorobie |
| ABCC9ATP binding cassette subfamily C member 9 | Często (30–79%) | W 1 chorobie |
| ACTC1actin alpha cardiac muscle 1 | Często (30–79%) | W 2 chorobach |
| ACTN2actinin alpha 2 | Często (30–79%) | W 1 chorobie |
| ANKRD1ankyrin repeat domain 1 | Często (30–79%) | W 1 chorobie |
| ATP5F1AATP synthase F1 subunit alpha | Często (30–79%) | W 1 chorobie |
| ATP5F1DATP synthase F1 subunit delta | Często (30–79%) | W 1 chorobie |
| ATP5F1EATP synthase F1 subunit epsilon | Często (30–79%) | W 1 chorobie |
| ATP5MKATP synthase membrane subunit k | Często (30–79%) | W 1 chorobie |
| ATP5POATP synthase peripheral stalk subunit OSCP | Często (30–79%) | W 1 chorobie |
| ATPAF2ATP synthase mitochondrial F1 complex assembly factor 2 | Często (30–79%) | W 1 chorobie |
| BAG3BAG cochaperone 3 | Często (30–79%) | W 1 chorobie |
| BAG5BAG cochaperone 5 | Często (30–79%) | W 1 chorobie |
| BMP2bone morphogenetic protein 2 | Często (30–79%) | W 2 chorobach |
| CAP2cyclase associated actin cytoskeleton regulatory protein 2 | Często (30–79%) | W 1 chorobie |
| CASRcalcium sensing receptor | Często (30–79%) | W 1 chorobie |
| CBLCbl proto-oncogene | Często (30–79%) | W 1 chorobie |
| COX7Bcytochrome c oxidase subunit 7B | Często (30–79%) | W 2 chorobach |
| CPT2carnitine palmitoyltransferase 2 | Często (30–79%) | W 3 chorobach |
| CRYABcrystallin alpha B | Często (30–79%) | W 1 chorobie |
| CSRP3cysteine and glycine rich protein 3 | Często (30–79%) | W 1 chorobie |
| DESdesmin | Często (30–79%) | W 1 chorobie |
Pokaż jeszcze 199 genów
| Gen | Jak często występuje | Choroby |
|---|---|---|
| DMDdystrophin | Często (30–79%) | W 3 chorobach |
| DOLKdolichol kinase | Często (30–79%) | W 2 chorobach |
| DSG2desmoglein 2 | Często (30–79%) | W 1 chorobie |
| DSPdesmoplakin | Często (30–79%) | W 1 chorobie |
| FHL2four and a half LIM domains 2 | Często (30–79%) | W 1 chorobie |
| FKTNfukutin | Często (30–79%) | W 1 chorobie |
| FLNCfilamin C | Często (30–79%) | W 1 chorobie |
| GATAD1GATA zinc finger domain containing 1 | Często (30–79%) | W 1 chorobie |
| GDAP1ganglioside induced differentiation associated protein 1 | Często (30–79%) | W 1 chorobie |
| GET3guided entry of tail-anchored proteins factor 3, ATPase | Często (30–79%) | W 1 chorobie |
| GNA11G protein subunit alpha 11 | Często (30–79%) | W 1 chorobie |
| GNB5G protein subunit beta 5 | Często (30–79%) | W 1 chorobie |
| GSNgelsolin | Często (30–79%) | W 1 chorobie |
| GYG1glycogenin 1 | Często (30–79%) | W 1 chorobie |
| HAND2heart and neural crest derivatives expressed 2 | Często (30–79%) | W 1 chorobie |
| HCCSholocytochrome c synthase | Często (30–79%) | W 2 chorobach |
| JPH2junctophilin 2 | Często (30–79%) | W 1 chorobie |
| KCNE1potassium voltage-gated channel subfamily E regulatory subunit 1 | Często (30–79%) | W 1 chorobie |
| KCNQ1potassium voltage-gated channel subfamily Q member 1 | Często (30–79%) | W 1 chorobie |
| KRASKRas proto-oncogene, GTPase | Często (30–79%) | W 1 chorobie |
| LAMA4laminin subunit alpha 4 | Często (30–79%) | W 1 chorobie |
| LDB3LIM domain binding 3 | Często (30–79%) | W 1 chorobie |
| LEMD2LEM domain nuclear envelope protein 2 | Często (30–79%) | W 1 chorobie |
| LMOD2leiomodin 2 | Często (30–79%) | W 1 chorobie |
| LZTR1leucine zipper like post translational regulator 1 | Często (30–79%) | W 1 chorobie |
| MRASmuscle RAS oncogene homolog | Często (30–79%) | W 1 chorobie |
| MT-ATP6mitochondrially encoded ATP synthase membrane subunit 6 | Często (30–79%) | W 3 chorobach |
| MT-ATP8mitochondrially encoded ATP synthase membrane subunit 8 | Często (30–79%) | W 1 chorobie |
| MYBPC3myosin binding protein C3 | Często (30–79%) | W 1 chorobie |
| MYH6myosin heavy chain 6 | Często (30–79%) | W 3 chorobach |
| MYH7myosin heavy chain 7 | Często (30–79%) | W 3 chorobach |
| MYPNmyopalladin | Często (30–79%) | W 1 chorobie |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Często (30–79%) | W 2 chorobach |
| NEXNnexilin F-actin binding protein | Często (30–79%) | W 1 chorobie |
| NPPAnatriuretic peptide A | Często (30–79%) | W 1 chorobie |
| NRAPnebulin related anchoring protein | Często (30–79%) | W 1 chorobie |
| NRASNRAS proto-oncogene, GTPase | Często (30–79%) | W 1 chorobie |
| PCCApropionyl-CoA carboxylase subunit alpha | Często (30–79%) | W 1 chorobie |
| PCCBpropionyl-CoA carboxylase subunit beta | Często (30–79%) | W 1 chorobie |
| PEX1peroxisomal biogenesis factor 1 | Często (30–79%) | W 2 chorobach |
| PEX6peroxisomal biogenesis factor 6 | Często (30–79%) | W 2 chorobach |
| PLNphospholamban | Często (30–79%) | W 1 chorobie |
| PNPLA2patatin like domain 2, triacylglycerol lipase | Często (30–79%) | W 1 chorobie |
| PPCSphosphopantothenoylcysteine synthetase | Często (30–79%) | W 1 chorobie |
| PRDM16PR/SET domain 16 | Często (30–79%) | W 2 chorobach |
| PSEN1presenilin 1 | Często (30–79%) | W 1 chorobie |
| PSEN2presenilin 2 | Często (30–79%) | W 1 chorobie |
| PSMB8proteasome 20S subunit beta 8 | Często (30–79%) | W 1 chorobie |
| RASA2RAS p21 protein activator 2 | Często (30–79%) | W 1 chorobie |
| RBM20RNA binding motif protein 20 | Często (30–79%) | W 1 chorobie |
| RIT1Ras like without CAAX 1 | Często (30–79%) | W 1 chorobie |
| RPL3Lribosomal protein L3 like | Często (30–79%) | W 1 chorobie |
| RRASRAS related | Często (30–79%) | W 1 chorobie |
| RRAS2RAS related 2 | Często (30–79%) | W 1 chorobie |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Często (30–79%) | W 1 chorobie |
| SCN5Asodium voltage-gated channel alpha subunit 5 | Często (30–79%) | W 3 chorobach |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Często (30–79%) | W 2 chorobach |
| SGCDsarcoglycan delta | Często (30–79%) | W 1 chorobie |
| SOS1SOS Ras/Rac guanine nucleotide exchange factor 1 | Często (30–79%) | W 1 chorobie |
| SOS2SOS Ras/Rho guanine nucleotide exchange factor 2 | Często (30–79%) | W 1 chorobie |
| SPRED2sprouty related EVH1 domain containing 2 | Często (30–79%) | W 1 chorobie |
| TAF1ATATA-box binding protein associated factor, RNA polymerase I subunit A | Często (30–79%) | W 1 chorobie |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Często (30–79%) | W 3 chorobach |
| TANGO2transport and golgi organization 2 homolog | Często (30–79%) | W 1 chorobie |
| TCAPtitin-cap | Często (30–79%) | W 1 chorobie |
| TMPOthymopoietin | Często (30–79%) | W 1 chorobie |
| TNNC1troponin C1, slow skeletal and cardiac type | Często (30–79%) | W 1 chorobie |
| TNNI3troponin I3, cardiac type | Często (30–79%) | W 1 chorobie |
| TNNT2troponin T2, cardiac type | Często (30–79%) | W 1 chorobie |
| TPM1tropomyosin 1 | Często (30–79%) | W 1 chorobie |
| TRPM4transient receptor potential cation channel subfamily M member 4 | Często (30–79%) | W 2 chorobach |
| TTRtransthyretin | Często (30–79%) | W 2 chorobach |
| TXNRD2thioredoxin reductase 2 | Często (30–79%) | W 1 chorobie |
| VCLvinculin | Często (30–79%) | W 1 chorobie |
| VEZF1vascular endothelial zinc finger 1 | Często (30–79%) | W 1 chorobie |
| WASWASP actin nucleation promoting factor | Często (30–79%) | W 1 chorobie |
| ACADMacyl-CoA dehydrogenase medium chain | Czasami (5–29%) | W 1 chorobie |
| AIPAHR interacting HSP90 co-chaperone | Czasami (5–29%) | W 1 chorobie |
| ALDOAaldolase, fructose-bisphosphate A | Czasami (5–29%) | W 1 chorobie |
| ASLargininosuccinate lyase | Czasami (5–29%) | W 1 chorobie |
| BTNL2butyrophilin like 2 | Czasami (5–29%) | W 1 chorobie |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Czasami (5–29%) | W 1 chorobie |
| CCND1cyclin D1 | Czasami (5–29%) | W 1 chorobie |
| CITED2Cbp/p300 interacting transactivator with ED-rich tail 2 | Czasami (5–29%) | W 1 chorobie |
| COL4A1collagen type IV alpha 1 chain | Czasami (5–29%) | W 1 chorobie |
| CPT1Acarnitine palmitoyltransferase 1A | Czasami (5–29%) | W 2 chorobach |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Czasami (5–29%) | W 1 chorobie |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Czasami (5–29%) | W 1 chorobie |
| FBXL4F-box and leucine rich repeat protein 4 | Czasami (5–29%) | W 1 chorobie |
| FHL1four and a half LIM domains 1 | Czasami (5–29%) | W 1 chorobie |
| FOXC2forkhead box C2 | Czasami (5–29%) | W 2 chorobach |
| GATA4GATA binding protein 4 | Czasami (5–29%) | W 1 chorobie |
| GATA6GATA binding protein 6 | Czasami (5–29%) | W 1 chorobie |
| GJA1gap junction protein alpha 1 | Czasami (5–29%) | W 2 chorobach |
| GLAgalactosidase alpha | Czasami (5–29%) | W 2 chorobach |
| GNAQG protein subunit alpha q | Czasami (5–29%) | W 1 chorobie |
| GPR101G protein-coupled receptor 101 | Czasami (5–29%) | W 1 chorobie |
| GTPBP3GTP binding protein 3, mitochondrial | Czasami (5–29%) | W 1 chorobie |
| HADHAhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha | Czasami (5–29%) | W 2 chorobach |
| HADHBhydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta | Czasami (5–29%) | W 1 chorobie |
| HDAC4histone deacetylase 4 | Czasami (5–29%) | W 1 chorobie |
| HLA-Bmajor histocompatibility complex, class I, B | Czasami (5–29%) | W 2 chorobach |
| HLA-DPA1major histocompatibility complex, class II, DP alpha 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DPB1major histocompatibility complex, class II, DP beta 1 | Czasami (5–29%) | W 1 chorobie |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Czasami (5–29%) | W 2 chorobach |
| HSPG2heparan sulfate proteoglycan 2 | Czasami (5–29%) | W 1 chorobie |
| KCNE3potassium voltage-gated channel subfamily E regulatory subunit 3 | Czasami (5–29%) | W 1 chorobie |
| LAMA2laminin subunit alpha 2 | Czasami (5–29%) | W 1 chorobie |
| LPIN1lipin 1 | Czasami (5–29%) | W 1 chorobie |
| MEFVMEFV innate immunity regulator, pyrin | Czasami (5–29%) | W 1 chorobie |
| MGAT2alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Czasami (5–29%) | W 1 chorobie |
| MGME1mitochondrial genome maintenance exonuclease 1 | Czasami (5–29%) | W 2 chorobach |
| MT-CO1mitochondrially encoded cytochrome c oxidase I | Czasami (5–29%) | W 3 chorobach |
| MT-CO3mitochondrially encoded cytochrome c oxidase III | Czasami (5–29%) | W 4 chorobach |
| MT-CYBmitochondrially encoded cytochrome b | Czasami (5–29%) | W 3 chorobach |
| MT-ND1mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 | Czasami (5–29%) | W 3 chorobach |
| MT-ND2mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 | Czasami (5–29%) | W 2 chorobach |
| MT-ND4mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 | Czasami (5–29%) | W 2 chorobach |
| MT-ND4Lmitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L | Czasami (5–29%) | W 2 chorobach |
| MT-ND5mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 | Czasami (5–29%) | W 3 chorobach |
| MT-ND6mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 | Czasami (5–29%) | W 3 chorobach |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Czasami (5–29%) | W 2 chorobach |
| NDUFS2NADH:ubiquinone oxidoreductase core subunit S2 | Czasami (5–29%) | W 1 chorobie |
| OBSCNobscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Czasami (5–29%) | W 1 chorobie |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Czasami (5–29%) | W 1 chorobie |
| PEX10peroxisomal biogenesis factor 10 | Czasami (5–29%) | W 1 chorobie |
| PEX11Bperoxisomal biogenesis factor 11 beta | Czasami (5–29%) | W 1 chorobie |
| PEX12peroxisomal biogenesis factor 12 | Czasami (5–29%) | W 1 chorobie |
| PEX13peroxisomal biogenesis factor 13 | Czasami (5–29%) | W 1 chorobie |
| PEX14peroxisomal biogenesis factor 14 | Czasami (5–29%) | W 1 chorobie |
| PEX16peroxisomal biogenesis factor 16 | Czasami (5–29%) | W 1 chorobie |
| PEX19peroxisomal biogenesis factor 19 | Czasami (5–29%) | W 1 chorobie |
| PEX2peroxisomal biogenesis factor 2 | Czasami (5–29%) | W 1 chorobie |
| PEX26peroxisomal biogenesis factor 26 | Czasami (5–29%) | W 1 chorobie |
| PEX3peroxisomal biogenesis factor 3 | Czasami (5–29%) | W 1 chorobie |
| PEX5peroxisomal biogenesis factor 5 | Czasami (5–29%) | W 1 chorobie |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Czasami (5–29%) | W 1 chorobie |
| POLGDNA polymerase gamma, catalytic subunit | Czasami (5–29%) | W 1 chorobie |
| POLG2DNA polymerase gamma 2, accessory subunit | Czasami (5–29%) | W 2 chorobach |
| PRTN3proteinase 3 | Czasami (5–29%) | W 1 chorobie |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Czasami (5–29%) | W 2 chorobach |
| RAI1retinoic acid induced 1 | Czasami (5–29%) | W 1 chorobie |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Czasami (5–29%) | W 1 chorobie |
| SALL4spalt like transcription factor 4 | Czasami (5–29%) | W 1 chorobie |
| SCN4Asodium voltage-gated channel alpha subunit 4 | Czasami (5–29%) | W 2 chorobach |
| SCUBE3signal peptide, CUB domain and EGF like domain containing 3 | Czasami (5–29%) | W 1 chorobie |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Czasami (5–29%) | W 1 chorobie |
| SDHCsuccinate dehydrogenase complex subunit C | Czasami (5–29%) | W 1 chorobie |
| SLC25A4solute carrier family 25 member 4 | Czasami (5–29%) | W 1 chorobie |
| SLC40A1solute carrier family 40 member 1 | Czasami (5–29%) | W 1 chorobie |
| SOX10SRY-box transcription factor 10 | Czasami (5–29%) | W 1 chorobie |
| SPECC1Lsperm antigen with calponin homology and coiled-coil domains 1 like | Czasami (5–29%) | W 1 chorobie |
| TBX20T-box transcription factor 20 | Czasami (5–29%) | W 1 chorobie |
| TBX3T-box transcription factor 3 | Czasami (5–29%) | W 2 chorobach |
| TLL1tolloid like 1 | Czasami (5–29%) | W 1 chorobie |
| TMEM70transmembrane protein 70 | Czasami (5–29%) | W 2 chorobach |
| TTPAalpha tocopherol transfer protein | Czasami (5–29%) | W 1 chorobie |
| TWNKtwinkle mtDNA helicase | Czasami (5–29%) | W 2 chorobach |
| VHLvon Hippel-Lindau tumor suppressor | Czasami (5–29%) | W 1 chorobie |
| ACADVLacyl-CoA dehydrogenase very long chain | Rzadko (1–4%) | W 1 chorobie |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Rzadko (1–4%) | W 1 chorobie |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Rzadko (1–4%) | W 1 chorobie |
| BMP6bone morphogenetic protein 6 | Rzadko (1–4%) | W 1 chorobie |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Rzadko (1–4%) | W 1 chorobie |
| CLCN1chloride voltage-gated channel 1 | Rzadko (1–4%) | W 1 chorobie |
| HBBhemoglobin subunit beta | Rzadko (1–4%) | W 2 chorobach |
| HFEhomeostatic iron regulator | Rzadko (1–4%) | W 2 chorobach |
| HRASHRas proto-oncogene, GTPase | Rzadko (1–4%) | W 2 chorobach |
| IVDisovaleryl-CoA dehydrogenase | Rzadko (1–4%) | W 1 chorobie |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Rzadko (1–4%) | W 2 chorobach |
| RHOBTB2Rho related BTB domain containing 2 | Rzadko (1–4%) | W 1 chorobie |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Rzadko (1–4%) | W 1 chorobie |
| SLC1A3solute carrier family 1 member 3 | Rzadko (1–4%) | W 1 chorobie |
| SLC2A1solute carrier family 2 member 1 | Rzadko (1–4%) | W 1 chorobie |
| CAV3caveolin 3 | Nie odnotowano | W 1 chorobie |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Nie odnotowano | W 1 chorobie |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Nie odnotowano | W 1 chorobie |
| ETFAelectron transfer flavoprotein subunit alpha | Nie odnotowano | W 1 chorobie |
| ETFBelectron transfer flavoprotein subunit beta | Nie odnotowano | W 1 chorobie |
| ETFDHelectron transfer flavoprotein dehydrogenase | Nie odnotowano | W 1 chorobie |
| GPC3glypican 3 | Nie odnotowano | W 1 chorobie |
| HJVhemojuvelin BMP co-receptor | Nie odnotowano | W 1 chorobie |
| MT-CO2mitochondrially encoded cytochrome c oxidase II | Nie odnotowano | W 1 chorobie |
| MT-TCmitochondrially encoded tRNA-Cys (UGU/C) | Nie odnotowano | W 1 chorobie |
| MT-TFmitochondrially encoded tRNA-Phe (UUU/C) | Nie odnotowano | W 1 chorobie |
| MT-THmitochondrially encoded tRNA-His (CAU/C) | Nie odnotowano | W 1 chorobie |
| MT-TKmitochondrially encoded tRNA-Lys (AAA/G) | Nie odnotowano | W 1 chorobie |
| MT-TL1mitochondrially encoded tRNA-Leu (UUA/G) 1 | Nie odnotowano | W 1 chorobie |
| MT-TQmitochondrially encoded tRNA-Gln (CAA/G) | Nie odnotowano | W 1 chorobie |
| MT-TS1mitochondrially encoded tRNA-Ser (UCN) 1 | Nie odnotowano | W 1 chorobie |
| MT-TS2mitochondrially encoded tRNA-Ser (AGU/C) 2 | Nie odnotowano | W 1 chorobie |
| MT-TVmitochondrially encoded tRNA-Val (GUN) | Nie odnotowano | W 1 chorobie |
| MT-TWmitochondrially encoded tRNA-Trp (UGA/G) | Nie odnotowano | W 1 chorobie |
| PEX7peroxisomal biogenesis factor 7 | Nie odnotowano | W 1 chorobie |
| PHYHphytanoyl-CoA 2-hydroxylase | Nie odnotowano | W 1 chorobie |
| SLC19A2solute carrier family 19 member 2 | Nie odnotowano | W 1 chorobie |
| SYNE2spectrin repeat containing nuclear envelope protein 2 | Nie odnotowano | W 1 chorobie |
| TDP2tyrosyl-DNA phosphodiesterase 2 | Nie odnotowano | W 1 chorobie |
| WIPI2WD repeat domain, phosphoinositide interacting 2 | Nie odnotowano | W 1 chorobie |
Jak często występuje wśród osób z jedną z chorób związanych z tym genem, najczęściej spośród wszystkich, według danych Human Phenotype Ontology. Te strony opisują cechy i badania, na których się opierają; nie są diagnozą, a w sprawie objawów należy zwrócić się do lekarza lub doradcy genetycznego.
Cechy podrzędne
Cechy nadrzędne
Skąd pochodzą te dane
- Human Phenotype Ontology, wydanie 2026-09-01: cecha, jej nazwy, definicja oraz geny z nią powiązane. Więcej informacji znajdą Państwo na stronie hpo.jax.org.
- Wydanie danych 2026.10.16-c6eea6bf.
Jeden test. Odpowiedzi na całe życie.
Od 449 $Bezpłatna wysyłka · Wyniki w ciągu 6–8 tygodni